Facilitated By

San Antonio Medical Foundation

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations

The purpose of this study will be to evaluate the immunogenicity and protective efficacy of pGX9501 (INO-4800) at a 0.5mg and 1 mg dose in the Rhesus macaque model of SARS-CoV-2 challenge.						

Texas Biomedical Research Institute
Carrion, Ricardo

Glioblastoma (GBM) is the most common and most aggressive of the primary malignant brain tumor in adults,with a median overall survival of 19.6 months following multi-modality therapy. The main limiting factor indelivering a tumoricidal radiation dose is the toxicity to surrounding brain. Therapeutic radionuclides, due to ashort tissue path and differences in radiobiology, have the potential to extend the therapeutic window for radiationin GBM.

UT Health San Antonio
Brenner, Andrew